You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 6, June 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Substance Abuse/ Alcoholism
 •Movement Disorders
 •Neurotoxicology
 •Parkinson Disease/ Parkinsonian Disorders
 •Neurology, Other
 •Public Health
 •Alert me on articles by topic

Manganese-Induced Parkinsonism Associated With Methcathinone (Ephedrone) Abuse

Rob M. A. de Bie, MD, PhD; Richard M. Gladstone, MD; Antonio P. Strafella, MD, PhD; Ji-Hyun Ko, MSc; Anthony E. Lang, MD

Arch Neurol. 2007;64(6):886-889.

Background  Manganese intoxication may lead to a levodopa-resistant, akinetic-rigid syndrome. A new form of presumed manganese poisoning has been reported in drug-addicted persons from Russia, Ukraine, and Estonia who have intravenously injected self-prepared methcathinone hydrochloride (Ephedrone).

Patient  A 36-year-old man from Azerbaijan with hepatitis C and only modest hepatic synthetic dysfunction developed rapid-onset, levodopa-resistant parkinsonism with profound hypophonia.

Conclusion  Ephedronic encephalopathy outside the region of the former Soviet Union may become a more widespread public health problem as a result of global travel and the easy availability of the recipe for synthesis of methcathinone on the Internet.


Author Affiliations: Movement Disorders Center, Division of Neurology (Drs de Bie, Strafella, and Lang), PET Imaging Centre, Center of Addiction Mental Health (Dr Strafella), University of Toronto, Toronto, Ontario; Department of Neurology, Academic Medical Center, Amsterdam, the Netherlands (Dr de Bie); and Montreal Neurological Institute, Brain Imaging Centre, McGill University, Montreal, Quebec (Mr Ko). Dr Gladstone is in private practice in Willowdale, Ontario.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.